NCT05761574View on ClinicalTrials.gov

A Study of an Acetaminophen/Naproxen Sodium Fixed Combination, Acetaminophen and Naproxen Sodium in Postoperative Dental Pain

PHASE3CompletedINTERVENTIONAL

Enrollment

447

Participants

Timeline

Start Date

May 22, 2023

Primary Completion Date

May 17, 2024

Study Completion Date

May 30, 2024

Conditions

Pain

Interventions

DRUG

Acetaminophen/Naproxen Sodium Fixed Combination

Fixed combination of Acetaminophen/Naproxen Sodium will be administered orally.

DRUG

Naproxen Sodium

Naproxen Sodium will be administered orally.

DRUG

Acetaminophen

Acetaminophen will be administered orally.

DRUG

Placebo

Placebo will be administered orally.

Trial Locations (1)

84107

JBR Clinical Research LLC, Salt Lake City

All Listed Sponsors

lead

Johnson & Johnson Consumer Inc. (J&JCI)

INDUSTRY

NCT05761574 - A Study of an Acetaminophen/Naproxen Sodium Fixed Combination, Acetaminophen and Naproxen Sodium in Postoperative Dental Pain | Biotech Hunter | Biotech Hunter